Trials / Conditions / Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
3 registered clinical trials studyying Acute Myeloid Leukemia/Transient Myeloproliferative Disorder.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia NCT01231919 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With NCT00322101 | Fred Hutchinson Cancer Center | Phase 3 |
| Completed | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Imm NCT00014235 | Fred Hutchinson Cancer Center | N/A |